About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New ‘Morning After’ Pill Safe, Efficient: FDA

by VR Sreeraman on June 16, 2010 at 4:12 PM
Font : A-A+

 New ‘Morning After’ Pill Safe, Efficient: FDA

A new "morning after" pill that can be taken up to five days after a sexual encounter is safe, efficient, and presents no unexpected side effects, US regulatory staff said in a report out Tuesday.

The report from Food and Drug Administration (FDA) staff comes ahead of a Thursday review by a panel that will issue a recommendation on approving the drug ulipristal -- produced by French pharmaceutical HRA Pharma -- for sale in the United States.

Advertisement

The FDA usually follows the panel's advice.

HRA Pharma, which already sells the pill in France, Britain and Germany, is hoping to market ulipristal in the United States under the name "Ella."
Advertisement

"Ella is an emergency contraceptive" to prevent pregnancy "following unprotected intercourse or a known or suspected contraceptive failure, the FDA said in a statement.

The drug, which can be used to end a pregnancy up to five days after a sexual encounter, "is not intended for routine use as a contraceptive," it said.

FDA staff looked at data for ulipristal that included 4,771 women who took the drug, including 2,764 that took the 30 milligram tablet that HRA Pharma hopes to sell in the United States.

"No deaths occurred and no unexpected adverse outcomes were observed in the clinical development program," read the FDA staff report.

"The most common adverse reactions were nausea, headache, dysmenorrhea (uterine pain), abdominal pain, fatigue, and dizziness."

The few serious side effects, such as a kidney infection and a ruptured cyst, seem to have been unrelated to treatment, the report said.

However data on the outcome of pregnancies "after EC (emergency contraceptive) failure with ulipristal were too limited to draw any definitive conclusions regarding the effect of ulipristal on an established pregnancy or fetal development."

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Heart Day in 2022- Use Heart for Every Heart
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
H1N1 Influenza Prevention in Children: What Parents Need to Know
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Vasectomy 

Most Popular on Medindia

Drug Interaction Checker Pregnancy Confirmation Calculator Diaphragmatic Hernia Sinopril (2mg) (Lacidipine) Hearing Loss Calculator Indian Medical Journals Blood - Sugar Chart Vent Forte (Theophylline) The Essence of Yoga Find a Hospital
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

New ‘Morning After’ Pill Safe, Efficient: FDA Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests